Just In: China Coronavirus Vaccine Shows Promising Results in Humans | CABLE REPORTERS
A testing vaccine developed in China has been established to be wonderful and able to generate an immune response against SARS-CoV-2, which causes COVID-19.
According to published research in The Lancet, the early-stage trial was conducted by researchers at several laboratories and included 108 participants aged 18 to 60.
The New York Times report reveals that those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks. Antibodies needed for immunity peaked at 28 days after the inoculation.
The trial is the first step in testing the vaccine and was intended mainly to verify its safety.
Proof of its potency will, however, require trials in thousands, perhaps hundreds of thousands, more people.
CABLE REPORTERS
0 Comments